AAAAAA

   
Results: 1-13 |
Results: 13
Phosphorylated map kinase (ERK1, ERK2) expression is associated with earlytau deposition in neurones and glial cells, but not with increased nuclearDNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
Authors: Ferrer, I Blanco, R Carmona, M Ribera, R Goutan, E Puig, B Rey, MJ Cardozo, A Vinals, F Ribalta, T
Citation: I. Ferrer et al., Phosphorylated map kinase (ERK1, ERK2) expression is associated with earlytau deposition in neurones and glial cells, but not with increased nuclearDNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration, BRAIN PATH, 11(2), 2001, pp. 144-158
Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
Authors: Ferrer, I Blanco, R Carmona, M Puig, B
Citation: I. Ferrer et al., Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration, NEUROP AP N, 27(5), 2001, pp. 343-351
Cleaved caspase-3, caspase-7 and poly (ADP-ribose) polymerase are complementarily but differentially expressed in human medulloblastomas
Authors: Puig, B Tortosa, A Ferrer, I
Citation: B. Puig et al., Cleaved caspase-3, caspase-7 and poly (ADP-ribose) polymerase are complementarily but differentially expressed in human medulloblastomas, NEUROSCI L, 306(1-2), 2001, pp. 85-88
Methylazoximethanol acetate-induced cell death in the granule cell layer of the developing mouse cerebellum is associated with caspase-3 activation, but does not depend on the tissue-type plasminogen activator
Authors: Ferrer, I Puig, B Goutan, E Gombau, L Munoz-Canoves, P
Citation: I. Ferrer et al., Methylazoximethanol acetate-induced cell death in the granule cell layer of the developing mouse cerebellum is associated with caspase-3 activation, but does not depend on the tissue-type plasminogen activator, NEUROSCI L, 299(1-2), 2001, pp. 77-80
Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease
Authors: Puig, B Ferrer, I
Citation: B. Puig et I. Ferrer, Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease, ACT NEUROP, 102(3), 2001, pp. 207-215
Fas and Fas ligand expression in Alzheimer's disease
Authors: Ferrer, I Puig, B Krupinski, J Carmona, M Blanco, R
Citation: I. Ferrer et al., Fas and Fas ligand expression in Alzheimer's disease, ACT NEUROP, 102(2), 2001, pp. 121-131
Prion protein expression in senile plaques in Alzheimer's disease
Authors: Ferrer, I Blanco, R Carmona, M Puig, B Ribera, R Rey, MJ Ribalta, T
Citation: I. Ferrer et al., Prion protein expression in senile plaques in Alzheimer's disease, ACT NEUROP, 101(1), 2001, pp. 49-56
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin
Authors: Mathoulin-Portier, MP Viens, P Cowen, D Bertucci, F Houvenaeghel, G Geneix, J Puig, B Bardou, VJ Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680
Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer
Authors: Cowen, D Houvenaeghel, G Bardou, VJ Jacquemier, J Bautrant, E Conte, M Viens, P Largillier, R Puig, B Resbeut, M Maraninchi, D
Citation: D. Cowen et al., Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer, INT J RAD O, 47(2), 2000, pp. 305-312
Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease
Authors: Ferrer, I Puig, B Blanco, R Marti, E
Citation: I. Ferrer et al., Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease, NEUROSCIENC, 97(4), 2000, pp. 715-726
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3
Authors: Jacquemier, J Mathoulin-Portier, MP Valtola, R Charafe-Jauffret, E Geneix, J Houvenaeghel, G Puig, B Bardou, VJ Hassoun, J Viens, P Birnbaum, D
Citation: J. Jacquemier et al., Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3, INT J CANC, 89(1), 2000, pp. 69-73
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy
Authors: Mathoulin-Portier, MP Meynard, P Charton-Bain, MC Escoute, M Bardou, VJ Puig, B Viens, P Cowen, D Houvenaeghel, G Hassoun, J Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy, ANTICANC R, 19(1B), 1999, pp. 843-847
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
Authors: Viens, P Jacquemier, J Bardou, VJ Bertucci, F Penault-Llorca, F Puig, B Gravis, G Oziel-Taieb, S Resbeut, M Houvenaeghel, G Camerlo, J Birbaum, D Hassoun, J Maraninchi, D
Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212
Risultati: 1-13 |